 "KRISHNA ELLA Executive Chairman, Bharat Biotech")
Saying he is a bit fatigued but ready to focus on his key projects like the tuberculosis (TB) vaccine, KRISHNA ELLA, executive chairman of Bharat Biotech, the makers of Covaxin and the nasal Covid vaccine iNCOVACC, shares his future plans in a conversation with Sohini Das at the biotech company's HQs in Hyderbad. Edited excerpts:
What is the next vaccine programme close to your heart after Covaxin?
We are working on the TB vaccine, as the Prime Minister’s view is also to eradicate TB from the country. We have one of the best TB vaccines in the world, and we are
